Committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients
A live webcast of the first half 2025 presentation will be available on August 27th at 08:00. Click her to join.
Latest news and press releases
Latest news and press releases
Radspherin®
Oncoinvents lead product candidate treats cancer in the peritoneal cavity
Description of the product
- Inorganic microparticles as carriers of alpha-emitters
- High-power radiation with a short range
- Short half-life of the radionuclide
- Microparticles which degrade slowly in the body
- Regional retention of effective radiation dose